Stock Information
Abcellera Biologics Inc (ABCL)
Ticker Symbol: ABCL
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $1,080.60 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.4904
Revenue (TTM): $0.25 M
Dividend Yield: N/A%
ROE: -14.79%
Latest News
-
Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next
Fri, Feb 27, 2026 2:09 AM
-
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M
Thu, Feb 26, 2026 7:28 PM
-
AbCellera Biologics Inc. Q4 2025 Earnings Call Summary
Thu, Feb 26, 2026 1:02 AM
-
Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Wed, Feb 25, 2026 5:22 AM
-
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
Wed, Feb 25, 2026 5:00 AM
-
What Sparked AbCellera Biologics To Soar Over 9% After Hours
Wed, Feb 25, 2026 4:51 AM
-
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
Wed, Feb 25, 2026 2:55 AM
Key Financials
Financial data not available
